CAS: 33386-08-2; Buspirone Hydrochloride

上下游产品

CAS号110-52-1 1,4-二溴丁烷 | CAS号20980-22-7 1-(2-嘧啶基)哌嗪 | CAS号1075-89-4 3,3-四亚甲基戊二酰亚胺 | CAS号1359159-58-2 8-(4,4-dimethox...

8-(4,4-二甲氧基丁基)-8-氮杂螺[4.5]癸烷-7,9-二酮置于盐酸,水,三乙酰氧基硼氢化钠,溶剂黄146体系中,用 二氯甲烷 作为反应溶剂,化学反应 2.83H,反应生成 丁螺旋酮盐酸盐
参考文献:通过胺的还原烷基化方法有效合成阿立哌唑,丁螺环酮和 Nan-190
标题:通过胺的还原烷基化方法有效合成阿立哌唑,丁螺环酮和 Nan-190
摘要:胺的还原烷基化程序用于合成阿立哌唑 1A,丁螺环酮 1B 和 Nan-190 1C.
DOI:10.1002/ardp.201100112

专利信息

专利号:US-11459325-B2
优先权日:2018-01-31
标题:Heterocyclic compound
发明人：TANAKA YUTA; OHASHI TOMOHIRO; IKEDA ZENICHI; TANAKA YUTA; PÃœNNER FLORIAN; YAMAMOTO TAKESHI; KAKEGAWA KEIKO; KIKUCHI FUMIAKI; MORISHITA NAO; KASAHARA TAKAHITO; SETO MASAKI; NAKAMURA MINORU; TAKAMI KAZUAKI; MURAKAMI MASATAKA; DAINI MASAKI; MIKAMI SATOSHI; SASAKI MINORU
权利人:TAKEDA PHARMACEUTICALS CO
摘要:The present invention provides a compound having a glucosylceramide lowering action (e.g., promoting glucosylceramide metabolism, inhibition of glucosylceramide synthesis, promoting glucosylceramide catabolism, etc.), which is expected to be useful as an agent for the prophylaxis or treatment of lysosome diseases (e.g., Gaucher's disease), neurodegenerative diseases (e.g., Parkinson's disease, Lewy body dementia, multiple-system atrophy) and the like. n The present invention relates to a compound represented by the formula (I): n nwherein each symbol is as described in the specification, or a salt thereof.

专利号:US-2014315720-A1
优先权日:2012-10-24
标 题 :Polysaccharide ester microspheres and methods and articles relating thereto
发明人：FALLON DENIS G; GARRETT THOMAS S; KIZER LAWTON E; ZAZZARA KAREN L; COMBS MICHAEL T; JOHNSON RICHARD K; DEHART GARY
权利人:CELANESE ACETATE LLC
摘要:A method for producing a polysaccharide ester microsphere may include forming a polysaccharide ester product from a polysaccharide synthesis, wherein the polysaccharide ester product comprises a polysaccharide ester and a solvent; diluting the polysaccharide ester product, thereby yielding a polysaccharide ester dope; and forming a plurality of polysaccharide ester microspheres from the polysaccharide ester dope. Suitable polysaccharides may include, but are not limited to, starch, cellulose, hemicellulose, algenates, chitosan, and any combination thereof. Esters thereof may be organic esters (e.g., acetate and the like), inorganic esters (e.g., sulfonates and the like), or combinations thereof. Further, the solids conent of the polysaccharide ester dope, in some instances, may be greater than about 16 wt %.